Massachusetts Financial Services Co. MA decreased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 23.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 281,806 shares of the health services provider's stock after selling 88,287 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 0.16% of Teladoc Health worth $2,562,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of TDOC. Versant Capital Management Inc grew its stake in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC acquired a new position in shares of Teladoc Health during the 4th quarter worth about $29,000. Lindbrook Capital LLC increased its holdings in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after acquiring an additional 1,612 shares during the last quarter. Generali Investments Management Co LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $64,000. Finally, PNC Financial Services Group Inc. lifted its stake in Teladoc Health by 22.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock worth $73,000 after purchasing an additional 1,439 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the stock. Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Royal Bank of Canada lifted their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Eleven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average target price of $10.94.
Read Our Latest Stock Analysis on TDOC
Teladoc Health Price Performance
Shares of TDOC traded down $0.06 during mid-day trading on Monday, hitting $7.19. The company's stock had a trading volume of 464,245 shares, compared to its average volume of 6,231,335. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1-year low of $6.61 and a 1-year high of $15.21. The firm has a market capitalization of $1.26 billion, a P/E ratio of -1.25 and a beta of 1.73. The firm has a 50-day simple moving average of $9.73 and a 200 day simple moving average of $9.70.
Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.95% of the stock is currently owned by company insiders.
Teladoc Health Company Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
